Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies [0.03%]
降压老策略之外:治疗考虑和联合疗法
T D Giles,G E Sander
T D Giles
Rapidly accumulating clinical data have repeatedly demonstrated not only the critical importance of even small increases in blood pressure as a pathophysiologic factor in the development of cardiovascular disease, particularly in individual...
Obesity and hypertension in children; caffeine, stress, and elevated blood pressure; resistant hypertension; and is it lowering of blood pressure alone that accounts for reduction in cardiovascular events? Comments on the JCH Contents [0.03%]
儿童肥胖和高血压;咖啡因、压力与血压升高;难治性高血压;单纯降低血压能否减少心血管事件?对JCH内容的评论
M Moser
M Moser
M Moser,N H Miller,M Jaffe et al.
M Moser et al.
Following a symposium on hypertension sponsored by the National Heart, Lung, and Blood Institute in San Francisco in April, 2000, a panel was convened to discuss the management of high‐risk hypertensive patients with comorbid diseases. The...
Current concepts of pharmacotherapy in hypertension: combination calcium channel blocker therapy in the treatment of hypertension [0.03%]
高血压的药物治疗概念:卡托普利与缓释型钙通道阻断剂联合用于降压治疗的观点
D A Sica
D A Sica
Effective control of blood pressure is usually achieved only with the use of two or more antihypertensive medications. The treatment options for hypertension are numerous, and the number of possible combinations large. The selection of a sp...
Advances in antihypertensive combination therapy: benefits of low-dose thiazide diuretics in conjunction with omapatrilat, a vasopeptidase inhibitor [0.03%]
低剂量噻嗪利尿剂与血管肽酶抑制剂奥马普利联合治疗高血压的优点
K C Ferdinand
K C Ferdinand
The preferred initial agents for the treatment of high blood pressure are low-dose thiazide diuretics, beta blockers, calcium antagonists, and angiotensin-converting enzyme (ACE) inhibitors. In high-risk patients, including those with diabe...